Antipsychotics (also known as neuroleptics or major tranquilizers) are a class of psychiatric medication primarily used to manage psychosis (including delusions, hallucinations, or disordered thought), in particular in schizophrenia and bipolar disorder.
In clinical trials of dopamine-blocking antipsychotics, significant adverse events may occur in healthy volunteers at dose levels that are well tolerated by schizophrenic patients. Because of these differences in tolerability, bioequivalence and pharmacokinetic studies of antipsychotics should be performed in schizophrenic patients rather than in healthy volunteers.
Related Journals of Bioequivalence Antipsychotics
Journal of Bioequivalence & Bioavailability, International Journal of BioAnalytical Methods & BioEquivalence Studies, Journal for Clinical Studies, MOJ Bioequivalence & Bioavailability, Bioequivalence Study Journal, Bioanalytical Methods & Bioequivalence Studies, Journal of Molecular Pharmaceutics & Organic Process Research, Enliven: Biosimilars and Bioavailablity, Chemical Speciation & Bioavailability, Pharmaceutical Regulatory Affairs: Open Access.